<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04744181</url>
  </required_header>
  <id_info>
    <org_study_id>0047459/20</org_study_id>
    <nct_id>NCT04744181</nct_id>
  </id_info>
  <brief_title>Patient Blood Management In CARdiac sUrgical patientS</brief_title>
  <acronym>ICARUS</acronym>
  <official_title>Patient Blood Management In CARdiac sUrgical patientS: the ICARUS Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nowadays up to 40% of patients undergoing cardiac surgery receives at least 1 unit of red&#xD;
      blood cell transfusion during surgery or during the first week after surgery. Moreover up to&#xD;
      40% of these patients shows an absolute or relative iron deficiency, with or without anaemia.&#xD;
&#xD;
      The objective of this study is to assess whether to implement an adequate correction of iron&#xD;
      according to current &quot;patients blood management&quot; recommendations might reduce RBC transfusion&#xD;
      requirements in patients undergoing heart surgery.&#xD;
&#xD;
      Data obtained in patients included in the study will be compared to those of a case-control&#xD;
      population selected from patients consecutively treated at the same department in the&#xD;
      previous 2 years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anemia is defined by the World Health Organization (WHO) as a value of hemoglobin (Hb) &lt; 130&#xD;
      g/L in men and &lt; 120 g/L in women. Anemia in surgical patients is a common and serious&#xD;
      problem, in fact up to 40% of patients presenting for major surgery are anemic. Patients with&#xD;
      pre-operative anemia have significantly higher rates of morbidity and mortality and are&#xD;
      likely to receive red blood cell (RBC) transfusions. In turn, RBC are independently&#xD;
      associated with worse outcome. Preoperative anemia mainly results from inadequate&#xD;
      erythropoiesis owing to iron deficiency. Iron deficiency anemia (IDA) has a complex origin,&#xD;
      including either absolute or functional iron deficiency (or iron sequestration). In absolute&#xD;
      iron deficiency, iron stores are severely decreased, resulting in anaemia (IDA). Conversely,&#xD;
      functional iron deficiency refers to insufficient iron mobilization despite normal or&#xD;
      elevated iron stores (iron deficient erythropoiesis, IDE).The most rapid and simple method to&#xD;
      correct anaemia is RBC transfusion. More than 30% of cardiac patients receives blood products&#xD;
      in the peri-operative phase. However, blood transfusion itself is not without risk: in the&#xD;
      setting of cardiac patients, even a single unit of blood transfused is reported to be&#xD;
      associated to increased morbidity and mortality. Specifically, blood transfusions in cardiac&#xD;
      surgery are associated with infections, ischemic postoperative morbidity, hospital stay,&#xD;
      increased early and late mortality, and greater hospital costs. Preoperative correction of&#xD;
      iron deficiency, with or without anaemia, is an integral part of the concept of the Patient&#xD;
      Blood Management (PBM). Iron supplementation would increase the availability of iron stores&#xD;
      and would trigger the process of erythropoiesis; the consequent relative lack of vitamin B12&#xD;
      and folic acid makes fundamental to restore also these 2 vitamins.&#xD;
&#xD;
      The objective of this study is to assess whether to implement an adequate correction of IDA&#xD;
      and IDE according to current PBM recommendations might reduce RBC transfusion requirements in&#xD;
      patients undergoing heart surgery. Data obtained in patients included in the study will be&#xD;
      compared to those of a case-control population selected from patients consecutively treated&#xD;
      at the same department in the previous 2 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 18, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients receiving RBC transfusion within post-operative day 7</measure>
    <time_frame>within post operative day 7</time_frame>
    <description>Percentage of patients receiving RBC transfusion within post-operative day 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hb values at last postoperative control within 7 days from surgery</measure>
    <time_frame>within post operative day 7</time_frame>
    <description>Hb values at last postoperative control within 7 days from surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay in ICU</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>length of stay in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of allogeneic blood products administered</measure>
    <time_frame>within the first 7 days post operative</time_frame>
    <description>number of allogeneic blood products administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of mechanical ventilation</measure>
    <time_frame>within the first 7 days post operative</time_frame>
    <description>duration of mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>acute kidney injury</measure>
    <time_frame>within the first 7 days post operative</time_frame>
    <description>worsening of renal function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serious adverse events</measure>
    <time_frame>within the first 12 hours after administration</time_frame>
    <description>including hypersensitivity reactions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>infections requiring antibiotic treatment</measure>
    <time_frame>within the first 7 days post operative</time_frame>
    <description>infections requiring antibiotic treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>within the first 7 days after surgery</time_frame>
    <description>patients died within the first 7 days after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>major adverse cardiac and cerebrovascular events</measure>
    <time_frame>within the first 7 days after surgery</time_frame>
    <description>cardiogenic shock, neurological events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost for the IDA/IDE treatment and blood product costs</measure>
    <time_frame>within the first 7 days after surgery</time_frame>
    <description>cost for the IDA/IDE treatment and blood product costs</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Anemia</condition>
  <condition>Blood Loss Anemia</condition>
  <condition>Iron-deficiency</condition>
  <condition>Iron Deficiency Anemia</condition>
  <condition>Iron Deficiency Anemia Treatment</condition>
  <condition>Erythropoiesis Abnormal</condition>
  <arm_group>
    <arm_group_label>cases</arm_group_label>
    <description>patients who fulfill the inclusion criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <description>Patients who underwent cardiac surgery in 2019 and 2018</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferric carboxymaltose</intervention_name>
    <description>administration of a single dose of ferric carboxymaltose in those patietns who fulfill the inclusion criteria</description>
    <arm_group_label>cases</arm_group_label>
    <other_name>ferinject</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>B vitamin</intervention_name>
    <description>administration of a single dose of B vitamin in those patietns who fulfill the inclusion criteria</description>
    <arm_group_label>cases</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Folic acid</intervention_name>
    <description>administration of a single dose of folic acid in those patietns who fulfill the inclusion criteria</description>
    <arm_group_label>cases</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients candidate to planned heart surgery in our tertiary care hospital are&#xD;
        eligible for the study purpose.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - all adult patients candidate to planned heart surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Know allergy to iron, or B vitamin, or folic acid&#xD;
&#xD;
          -  Hyperferritinemia (ferritin blood value &gt; 300 ng/ml).&#xD;
&#xD;
          -  patient's refusal&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>filippo corsi, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>filippo corsi, Dr</last_name>
    <phone>+390630154848</phone>
    <email>filippo.corsi@policlinicogemelli.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>FPG Fondazione Policlinico Gemelli IRCCS</name>
      <address>
        <city>Roma</city>
        <zip>00100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>filippo corsi</last_name>
      <phone>3338257652</phone>
      <email>filippo.corsi@policlinicogemelli.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf?ua=1</url>
    <description>Haemoglobin concentration for the diagnosis of anaemia and assesment of severity</description>
  </link>
  <link>
    <url>https://linkinghub.elsevier.com/retrieve/pii/S1053-0770(19)30639-1</url>
    <description>Perioperative Anemia Management as Part of PBM in Cardiac Surgery - A Narrative Updated Review</description>
  </link>
  <link>
    <url>https://research-repository.uwa.edu.au/en/publications/the-impact-of-anaemia-and-intravenous-iron-replacement-therapy-on</url>
    <description>The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery</description>
  </link>
  <link>
    <url>https://linkinghub.elsevier.com/retrieve/pii/S0022-5223(16)30564-5</url>
    <description>Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery?</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/abs/pii/S0883944116310553?via%3Dihub</url>
    <description>The impact of minor blood transfusion on the outcome after coronary artery bypass grafting</description>
  </link>
  <link>
    <url>https://ashpublications.org/blood/article/123/5/615/32839/A-systematic-analysis-of-global-anemia-burden-from</url>
    <description>A systematic analysis of global anemia burden from 1990 to 2010</description>
  </link>
  <link>
    <url>https://www.nejm.org/doi/10.1056/NEJMra1401038?url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org&amp;rfr_dat=cr_pub++0pubmed</url>
    <description>Iron-Deficiency Anemia</description>
  </link>
  <link>
    <url>https://linkinghub.elsevier.com/retrieve/pii/S1053-0770(19)30108-9</url>
    <description>Impact of Preoperative Iron Deficiency on Blood Transfusion in Elective Cardiac Surgery</description>
  </link>
  <link>
    <url>https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.030099?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed</url>
    <description>Anemia and Iron Deficiency in Heart Failure</description>
  </link>
  <link>
    <url>https://journals.sagepub.com/doi/10.1177/2047487317689975?url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org&amp;rfr_dat=cr_pub++0pubmed&amp;</url>
    <description>Patterns and determinants of functional and absolute iron deficiency in patients undergoing cardiac rehabilitation following heart surgery</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993224/</url>
    <description>Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S0735109711017001?via%3Dihub</url>
    <description>Myocardial and Systemic Iron Depletion in Heart Failure: Implications for Anemia Accompanying Heart Failure</description>
  </link>
  <link>
    <url>https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3200-3</url>
    <description>Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - the study design of the LIBERAL-Trial</description>
  </link>
  <link>
    <url>https://www.trasci.com/article/S1473-0502(19)30108-9/fulltext</url>
    <description>Patient blood management in the cardiac surgical setting: An updated overview</description>
  </link>
  <results_reference>
    <citation>Spahn DR, Schoenrath F, Spahn GH, Seifert B, Stein P, Theusinger OM, Kaserer A, Hegemann I, Hofmann A, Maisano F, Falk V. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet. 2019 Jun 1;393(10187):2201-2212. doi: 10.1016/S0140-6736(18)32555-8. Epub 2019 Apr 26.</citation>
    <PMID>31036337</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 31, 2021</study_first_submitted>
  <study_first_submitted_qc>February 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</investigator_affiliation>
    <investigator_full_name>CORSI FILIPPO</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Deficiency Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will be shared upon reasonable request to the PI and after approval by ethic committee.</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://redcap-irccs.policlinicogemelli.it/</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

